The MarketWatch News Department was not involved in the creation of this content. INVESTOR DEADLINE: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead Class Action ...
IMMUNITYBIO, INC. CLASS ACTION LAWSUIT - COMPLAINT ALLEGATION SUMMARY: The complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results